Faruqi and Faruqui, LLP Logo
Share this page

Thoratec Corp. (THOR)

NASDAQGS:THOR

Summary

Faruqi & Faruqi, LLP Announces the Investigation of Thoratec Corp. (THOR) Over the Proposed Sale of the Company to St. Jude Medical Inc.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Thoratec Corp. (“Thoratec” or the “Company”) (NASDAQGS:THOR) for potential breaches of fiduciary duties in connection with the sale of the Company to St. Jude Medical Inc. for approximately $3.4 billion.

The Company’s stockholders will only receive $63.50 for each share of Company common stock they own. The offer represents a mere 10 percent premium over Thortec's Friday, July 17th, closing price per share and a negligible premium over Thortec's Wednesday, July 22nd, opening price per share. Furthermore, the Company’s price per share is expected to continue climbing.

If you own common stock in Thoratec and wish to obtain additional information and protect your investments free of charge, please fill out the form below or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330. 

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.

  • Company:
    Thoratec Corp. (THOR)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Juan E. Monteverde
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 07/22/2015

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.